Main > RHEUMATOLOGY > USA. A. nr-axSpA>Treat.>JAK Inh. Ta

---

b

USA. A. nr-axSpA>Treat.>JAK Inh. Ta's subsections
(*) EU CE Mark Date: 2022. 07.29
(*) USA Approval Date: 2022. 10.21
Company
Generic Name: Upadacitinib
JAK: JAnus Kinase
nr-axSpA: non-radiographic axial Sp
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 14
Patent>UpDate: 2022. 06.28
RTM
RTM Web-Site

USA. A. nr-axSpA>Treat.>JAK Inh. Ta's products
This section has no products